Physician profile
Jon Ivey
NPI 1336437797
$2,955.03
in general payments reported to CMS, 2019-2025
14 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $810 · 2020: $133 · 2021: $464 · 2022: $747 · 2023: $148 · 2024: $537 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734 · Long Term Medical Supply Or Device Loan: $66.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.73 |
| Long Term Medical Supply Or Device Loan | $66.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $906.52 | 2019-2022 | |
| Abbvie INC. | $540.44 | 2023-2025 | |
| Sientra, INC. | $354.05 | 2021-2022 | |
| Mentor Worldwide LLC | $247.75 | 2019 | |
| Revance Therapeutics, INC. | $144.69 | 2024-2025 | Daxxify |
| Kls-Martin L.P. | $133.43 | 2020 | |
| Acera Surgical, INC. | $124.04 | 2019 | |
| Stryker Corporation | $113.22 | 2019 | |
| Kci USA, INC. | $105.50 | 2019 | |
| Derma Sciences, INC. | $83.73 | 2019 | |
| Integra Lifesciences Corporation | $66.46 | 2024 | Acell |
| Endo Pharmaceuticals INC. | $64.27 | 2021-2022 | |
| Axogen | $48.60 | 2023 | Avance Nerve Graft |
| Galderma Laboratories, L.P. | $22.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Ivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.